Dr Muhand S El-twal, MD - Medicare Internal Medicine in Taunton, MA

Dr Muhand S El-twal, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Taunton, Massachusetts. His current practice location is 88 Washington St, Morton Hospital & Medical Center, Taunton, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (508) 821-9989.

Dr Muhand S El-twal is licensed to practice in Massachusetts (license number 158795) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1245229384.

Contact Information

Dr Muhand S El-twal, MD
88 Washington St, Morton Hospital & Medical Center,
Taunton, MA 02780-2465
(508) 821-9989
Not Available



Physician's Profile

Full NameDr Muhand S El-twal
GenderMale
SpecialityInternal Medicine - Nephrology
Location88 Washington St, Taunton, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1245229384
  • Provider Enumeration Date: 10/20/2005
  • Last Update Date: 12/14/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 1456338037
  • Enrollment ID: I20070821000159

Medical Identifiers

Medical identifiers for Dr Muhand S El-twal such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1245229384NPI-NPPES
7008893MedicaidRI
2001781MedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 158795 (Massachusetts)Primary
207RN0300XInternal Medicine - Nephrology MD10460 (Rhode Island)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Muhand S El-twal allows following entities to bill medicare on his behalf.
Entity NameCd Practice Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295787919
PECOS PAC ID: 2567359839
Enrollment ID: O20040302000290

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameSound Physicians Of Massachusetts Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740678408
PECOS PAC ID: 2062554637
Enrollment ID: O20100120000133

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629398219
PECOS PAC ID: 2860688728
Enrollment ID: O20101119000007

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629398219
PECOS PAC ID: 2860688728
Enrollment ID: O20101119000332

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameSound Physicians Of Massachusetts Ii Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306376397
PECOS PAC ID: 9436421567
Enrollment ID: O20170823003703

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameOsler Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851869069
PECOS PAC ID: 4587900915
Enrollment ID: O20190107001048

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Entity NameIncare Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639655467
PECOS PAC ID: 1153658851
Enrollment ID: O20190802001626

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Muhand S El-twal is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Muhand S El-twal, MD
91 Stiles Rd, Attn Sharon Silva,
Salem, NH 03079-5804

Ph: (603) 893-9784
Dr Muhand S El-twal, MD
88 Washington St, Morton Hospital & Medical Center,
Taunton, MA 02780-2465

Ph: (508) 821-9989

News Archive

Altering visual cues can impact chronic neck pain

Using virtual reality to misrepresent how far the neck is turned can actually change pain experiences in individuals who suffer from chronic neck pain, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Siemens Healthineers expands informatics capabilities for point-of-care testing with acquisition of Conworx Technology

Siemens Healthineers announced today the company is expanding its informatics capabilities for point-of-care testing with the acquisition of Conworx Technology GmbH, the Berlin-based developer of point-of-care device interfaces and data management solutions.

Elsevier, SIOG launch Journal of Geriatric Oncology

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) announced today the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the pathogenesis, biology, treatment, and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

Octapharma enrolls first patients in GAM-27 Phase II/III clinical trial for relapsing multiple sclerosis

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Taunton, MA

Priti A Patel, MD
Nephrology
Medicare: May Accept Medicare Assignments
Practice Location: 233 Winthrop Street, Taunton, MA 02780
Phone: 508-880-0070    Fax: 508-880-2989
Robert J Mcnamee, M.D.
Nephrology
Medicare: Medicare Enrolled
Practice Location: 72 Washington St, Suite 1300, Taunton, MA 02780
Phone: 508-824-5865    Fax: 508-823-9108
Kabir Chuttani, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 72 Washington St, Suite 1400-1700, Taunton, MA 02780
Phone: 508-880-0077    Fax: 508-880-5247
Yun Xia, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 100 Industrial Park Rd, Suite 1, Taunton, MA 02780
Phone: 508-822-2266    Fax: 508-823-5689
Cristina Cellurale, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 91 Washington St Unit 301, Taunton, MA 02780
Phone: 508-824-5865    Fax: 508-823-9108
Khalid A Zaalook, M.D.
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: Morton Hospital & Medical Center, 88 Washington Street, Taunton, MA 02780
Phone: 508-828-7293    
Yelena Levin, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 152 Dean St, Taunton, MA 02780
Phone: 508-824-3872    Fax: 508-828-4925

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.